The data presented above demonstrate that FABP5, which functions to selectively deliver ligands to the nuclear receptor PPARβ/δ, is under the direct control of its cognate nuclear receptor in prostate cancer cells. The gene discussed is FABP5; the disease is prostate carcinoma.